The ongoing debate of who to treat for chronic hepatitis c virus

JAMA Internal Medicine

Volumn 175, Issue 2, 2015, Pages 169-170

  Ghany, Marc G ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIMEPREVIR; SOFOSBUVIR;

ALCOHOL ABUSE; DECOMPENSATED LIVER CIRRHOSIS; DISEASE COURSE; EDITORIAL; HEMODIALYSIS; HEPATITIS B VIRUS; HEPATITIS C; HISTORY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER GRAFT; MEN WHO HAVE SEX WITH MEN; PHYSICIAN; PRIORITY JOURNAL; THERAPY DELAY; TREATMENT OUTCOME; UNITED STATES; VETERAN; WATERSHED; COMPLICATION; FEMALE; MALE; VIROLOGY;

FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE;

EID: 84922216263     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.4299     Document Type: Editorial

References (17)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-2128
2. Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. 2010;138 (2):513-521
3. Van Der Meer AJ, Veldt BJ, Feld JJ, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and adVanced hepatic fibrosis. JAMA. 2012;308(24):2584-2593
4. Holmberg SD, Spradling PR, Moorman AC, Denniston MM. Hepatitis C in the United States. N Engl J Med. 2013;368(20):1859-1861
5. Seeff LB. Natural history of chronic hepatitis C. Hepatology. 2002;36(5)(suppl 1):S35-S46
6. Kenny-Walsh E; Irish Hepatology Research Group. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J Med. 1999;340(16):1228-1233
7. Wiese M, Fischer J, Lbermann M, et al; East German HCV Study Group. Evaluation of liver disease progression in the German hepatitis C virus (1b)-contaminated anti-D cohort at 35 years after infection. Hepatology. 2014;59(1):49-57
8. Butt AA, Yan P, Lo Re V III, et al; ERCHIVES (Electronically Retrieved Cohort of HCV Infected Veterans) Study Team. Liver fibrosis progression in hepatitis C virus infection after seroconversion [published online December 8, 2014]. JAMA Intern Med. doi:10.1001/jamainternmed.2014.6502
9. Ferenci P, Bernstein D, Lalezari J, et al; PEARL-III Study; PEARL-IV Study. ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV. N Engl J Med. 2014;370(21):1983-1992
10. Afdhal N, Zeuzem S, Kwo P, et al; ION-1 Investigators. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med. 2014;370(20):1889-1898
11. Manns M, Pol S, Jacobson IM, et al; HALLMARK-DUAL Study Team. All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study [published online July 28, 2014]. Lancet. doi:10 .1016/S0140-6736(14)61059-X
12. Just SA, Grau K, Georgsen J, et al; Danish HCV Lookback Group. Long-term follow-up among Danish transfusion recipients identified in the national hepatitis C lookback. Transfusion. 2012;52 (3):582-588
13. Sofosbuvir (Sovaldi) for chronic hepatitis C. Med Lett Drugs Ther. 2014;56(1434):5-6
14. Simeprevir (Olysio) for chronic hepatitis C. Med Lett Drugs Ther. 2014;56(1433):1-3
15. Milliman Inc. Health care reform and hepatitis C: a convergence of risk and opportunity. http://us .milliman.com/uploadedFiles/insight/2013/healthcare-reform-hepatitis-c.pdf. Accessed August 4th, 2014
16. American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. http://www.hcvguidelines.org/. Accessed August 8, 2014
17. Grebely J, Pham ST, Matthews GV, et al; ATAHC Study Group. Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection. Hepatology. 2012;55(4):1058-1069